Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04427787 |
| Title | A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET (LOLA) |
| Acronym | LOLA |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |